BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 6968167)

  • 1. Interrelationships between serum chemotactic factor inactivator, alpha 1-antitrypsin deficiency, and chronic obstructive lung disease.
    Lam S; Chan-Yeung M; Abboud R; Kreutzer D
    Am Rev Respir Dis; 1980 Mar; 121(3):507-12. PubMed ID: 6968167
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The prevalence of alpha-antitrypsin heterozygotes (Pi MZ) in patients with obstructive pulmonary disease.
    Shigeoka JW; Hall WJ; Hyde RW; Schwartz RH; Mudholkar GS; Speers DM; Lin CC
    Am Rev Respir Dis; 1976 Dec; 114(6):1077-84. PubMed ID: 1087539
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical features of individuals with PI*SZ phenotype of alpha 1-antitrypsin deficiency. alpha 1-Antitrypsin Deficiency Registry Study Group.
    Turino GM; Barker AF; Brantly ML; Cohen AB; Connelly RP; Crystal RG; Eden E; Schluchter MD; Stoller JK
    Am J Respir Crit Care Med; 1996 Dec; 154(6 Pt 1):1718-25. PubMed ID: 8970361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Phenotype Pi and alpha 1 antitrypsin deficiency in types A and B chronic obstructive bronchopneumopathies].
    Dyan A; Martin JP; Saint-Paul M; Baud F; Bignon J
    Pathol Biol (Paris); 1975 Sep; 23(7):525-33. PubMed ID: 1101155
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A family study of the variability of pulmonary function in alpha 1-antitrypsin deficiency. Quantitative phenotypes.
    Silverman EK; Province MA; Rao DC; Pierce JA; Campbell EJ
    Am Rev Respir Dis; 1990 Nov; 142(5):1015-21. PubMed ID: 2240821
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alpha 1-antitrypsin Pi-types in 965 COPD patients.
    Lieberman J; Winter B; Sastre A
    Chest; 1986 Mar; 89(3):370-3. PubMed ID: 3485034
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence for excessive bronchial inflammation during an acute exacerbation of chronic obstructive pulmonary disease in patients with alpha(1)-antitrypsin deficiency (PiZ).
    Hill AT; Campbell EJ; Bayley DL; Hill SL; Stockley RA
    Am J Respir Crit Care Med; 1999 Dec; 160(6):1968-75. PubMed ID: 10588615
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intermediate alpha1-antitrypsin deficiency and chronic obstructive pulmonary disease in Yugoslavia.
    Kozarevic D; Laban M; Budimir M; Vojvodic N; Roberts A; Gordon T; McGee DL
    Am Rev Respir Dis; 1978 Jun; 117(6):1039-43. PubMed ID: 307352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum levels and genotype distribution of α1-antitrypsin in the general population.
    Ferrarotti I; Thun GA; Zorzetto M; Ottaviani S; Imboden M; Schindler C; von Eckardstein A; Rohrer L; Rochat T; Russi EW; Probst-Hensch NM; Luisetti M
    Thorax; 2012 Aug; 67(8):669-74. PubMed ID: 22426792
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alpha 1-antitrypsin phenotypes and obstructive lung disease in the city of Oslo.
    Gulsvik A; Fagerhol MK
    Scand J Respir Dis; 1979 Oct; 60(5):267-74. PubMed ID: 316573
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relation of protease inhibitor phenotypes to obstructive lung diseases in a community.
    Morse JO; Lebowitz MD; Knudson RJ; Burrows B
    N Engl J Med; 1977 May; 296(21):1190-4. PubMed ID: 300842
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interrelationships between neutrophil elastase, serum alpha, -antitrypsin, lung function and chest radiography in patients with chronic airflow obstruction.
    Abboud RT; Rushton JM; Grzybowski S
    Am Rev Respir Dis; 1979 Jul; 120(1):31-40. PubMed ID: 313728
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deficient alpha-1-antitrypsin phenotypes and persistent airflow limitation in severe asthma.
    van Veen IH; ten Brinke A; van der Linden AC; Rabe KF; Bel EH
    Respir Med; 2006 Sep; 100(9):1534-9. PubMed ID: 16476537
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liver Phenotypes of European Adults Heterozygous or Homozygous for Pi∗Z Variant of AAT (Pi∗MZ vs Pi∗ZZ genotype) and Noncarriers.
    Schneider CV; Hamesch K; Gross A; Mandorfer M; Moeller LS; Pereira V; Pons M; Kuca P; Reichert MC; Benini F; Burbaum B; Voss J; Gutberlet M; Woditsch V; Lindhauer C; Fromme M; Kümpers J; Bewersdorf L; Schaefer B; Eslam M; Bals R; Janciauskiene S; Carvão J; Neureiter D; Zhou B; Wöran K; Bantel H; Geier A; Dirrichs T; Stickel F; Teumer A; Verbeek J; Nevens F; Govaere O; Krawczyk M; Roskams T; Haybaeck J; Lurje G; Chorostowska-Wynimko J; Genesca J; Reiberger T; Lammert F; Krag A; George J; Anstee QM; Trauner M; Datz C; Gaisa NT; Denk H; Trautwein C; Aigner E; Strnad P;
    Gastroenterology; 2020 Aug; 159(2):534-548.e11. PubMed ID: 32376409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. alpha 2-Macroglobulin in patients with obstructive lung disease, with and without alpha 1-antitrypsin deficiency.
    Brissenden JE; Cox DW
    Clin Chim Acta; 1983 Mar; 128(2-3):241-8. PubMed ID: 6189643
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Collaborative study to assess risk of lung disease in Pi MZ phenotype subjects.
    Bruce RM; Cohen BH; Diamond EL; Fallat RJ; Knudson RJ; Lebowitz MD; Mittman C; Patterson CD; Tockman MS
    Am Rev Respir Dis; 1984 Sep; 130(3):386-90. PubMed ID: 6332562
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical, epidemiologic, and pulmonary function studies in alpha,-antitrypsin-deficient subjects of Pi Z type.
    Rawlings W; Kreiss P; Levy D; Cohen B; Menkes H; Brashears S; Permutt S
    Am Rev Respir Dis; 1976 Nov; 114(5):945-53. PubMed ID: 1086622
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relation of functional characteristics and serum alpha-1-antitrypsin (AAT) concentration in patients with PiMM phenotype and chronic obstructive pulmonary disease (COPD).
    Zarić B; Stojčević J; Andrijević L; Andrijević I; Kuruc V; Veselinović I; Salatić I
    Eur J Intern Med; 2011 Dec; 22(6):603-6. PubMed ID: 22075288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interactions of neutrophil elastase, serum trypsin inhibitory activity, and smoking history as risk factors for chronic obstructive pulmonary disease in patients with MM, MZ, and ZZ phenotypes for alpha-antitrypsin.
    Galdston M; Melnick EL; Goldring RM; Levytska V; Curasi CA; Davis AL
    Am Rev Respir Dis; 1977 Nov; 116(5):837-46. PubMed ID: 303486
    [No Abstract]   [Full Text] [Related]  

  • 20. The Effects of Inflammation on Alpha 1 Antitrypsin Levels in a National Screening Cohort.
    Sanders CL; Ponte A; Kueppers F
    COPD; 2018 Feb; 15(1):10-16. PubMed ID: 29381093
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.